Nanoparticles for Drug Delivery

Webcast

On Demand Webcast Nanoparticles have unique properties that are manipulated to create novel solutions, such as innovative drug delivery systems seen in today’s Covid-19 mRNA vaccines. This webinar explores the analytical techniques used for nanoparticle characterization and its growing significance in drug delivery systems.

Register free: https://www.pharmtech.com/pt/Delivery

Event Overview:

TNanoparticles have unique properties that are manipulated to create novel solutions, with its most significant contribution in the field of drug delivery. One of the major fields of nanotechnology research is the application of nanoparticles used for drug delivery, with considerable research and development devoted to this field. Because nanoparticle size and surface properties are critical physical parameters influencing behavior, proper particle size analysis is essential in both research and development, and ultimately in quality control. In this webinar, Mark Bumiller, Technology Manager, will explore the analytical techniques used for nanoparticle characterization and its growing significance in novel drug delivery systems.

Key Learning Objectives:

  • Definition of nanoparticles and its benefits for drug delivery
  • Nanoparticle drugs on the market
  • Low concentration measurements (1 nm to 1 μm) using Dynamic Light Scattering (DLS)

Who Should Attend:

  • Quality/Process Control
  • Biopharma/academic research and development labs
  • USP 729, drug delivery

Speakers:

Mark Bumiller
Technology Manager, Scientific Instruments
Entegris

Mark has worked in the field of particle size analysis for over 35 years. Positions held include product manager at Hiac Royco (5 years), technical support manager and vice president of business development at Malvern Instruments (17 years), vice president of particle products at Horiba (6 years) and technology manager at Particle Sizing Systems, LLC, and now Entegris (6 years).

He has served as a member of the expert committee for USP <788>, the executive committee of the International Fine Particle Research Institute (IFPRI), and the executive committee of Particle Technology Forum of the American Institute of Chemical Engineers.

Mark is an active member of Technical Committee 24 within ISO helping to write standards for particle size and zeta potential analysis. His B.S. in chemical engineering was earned at Carnegie Mellon University in Pittsburgh, PA

Sponsor: Entegris

Register free
: https://www.pharmtech.com/pt/Delivery